Funding for this research was provided by:
National Human Genome Research Institute (5U54HG003067-13)
Received: 17 November 2017
Accepted: 4 January 2018
First Online: 29 January 2018
Ethics approval and consent to participate
: Recruitment protocols were approved by the appropriate institutional review boards (IRBs) at each HMP clinical site (Baylor College of Medicine, IRB protocols H-22895 (IRB 00001021) and H-22035 (IRB 00002649)); Washington University School of Medicine (IRB protocol HMP-07-001 (IRB 201105198)); and St. Louis University (IRB 15778). Written informed consent was obtained from all study participants to participate in the study and to allow data sharing through dbGaP. All participants consented for the sequencing of their own genetic material [CitationRef removed]. Research on human subjects was performed in accordance with the Declaration of Helsinki. The study was also reviewed by the J. Craig Venter Institute under IRB protocol 2008–084 (IRB 00003721). The study was determined to be exempt from IRB review at the Broad Institute.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.